Evidence supporting the use of: Eicosapentaenoic Acid
For the health condition: Peripheral Neuropathy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid found primarily in fish oil. Its use in supporting or treating peripheral neuropathy is grounded in emerging scientific research rather than traditional medicine. Peripheral neuropathy, characterized by nerve damage resulting in pain, numbness, and tingling, is often associated with diabetes and chemotherapy.

Some small clinical studies and animal models suggest that EPA, often in combination with docosahexaenoic acid (DHA), may have neuroprotective and anti-inflammatory effects that could benefit patients with peripheral neuropathy. Mechanistically, EPA can be incorporated into cell membranes, modulate inflammatory pathways, and potentially reduce oxidative stress and nerve injury. A few randomized controlled trials have examined omega-3 supplementation in diabetic neuropathy and chemotherapy-induced peripheral neuropathy, showing modest improvements in symptoms or nerve conduction; however, these studies are generally limited by small sample sizes, short durations, or the use of combined omega-3 formulations rather than EPA alone.

While the mechanistic rationale is plausible and preliminary studies are somewhat encouraging, the overall quality and amount of evidence is still limited. Most professional guidelines do not currently recommend EPA as a standard treatment for peripheral neuropathy due to insufficient robust clinical data. As such, the evidence rating is low (2/5), reflecting weak but suggestive scientific support rather than strong validation.

More about Eicosapentaenoic Acid
More about Peripheral Neuropathy

Products containing Eicosapentaenoic Acid

We currently have no products on Vitabase that contain this ingredient.